Manufacturing

Review of SUT Adoption in Biopharma Manufacturing

The evolution of therapeutic modalities drives the adoption of single-use technologies.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Automating the Future of Fill/Finish

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

Don’t Gamble on Tablet Tooling Maintenance

May 16, 2022

By following some fundamental steps, manufacturers can optimize their tablet tooling maintenance and resulting productivity.

Implementing Continuous Bioprocessing: From Theory to Practice

May 16, 2022

The struggle to implement continuous biomanufacturing at GMP level is slowly advancing.

The Lighthouse Effect: Using Technology to Improve Life Sciences Manufacturing

May 15, 2022

Lighthouse manufacturing techniques utilize technology and automation to streamline production.

Plan Early: Optimizing Stability During Lyophilization

May 15, 2022

The need for sustainability and early considerations of a lyophilization strategy grow more pertinent on the back of growing biologics volume.

Opportunities for Growth and Breakthroughs for Cell and Gene Therapies

May 15, 2022

CGTs offer hope for the future of treatments, but the costly manufacturing, slow turnaround time, and need for supplies hinder progress.

Converting Injectable Therapies to Combination Drug-Device Products

May 15, 2022

The author describes how to seize market opportunities while navigating the requirements of both drug therapies and delivery devices.

Using Robotics in the Aseptic Manufacturing Facility of the Future

May 15, 2022

Several steps need be taken to achieve lights-out, fully automated operations.

Avantor and Cytovance Biologics Partner on Plasmid DNA Development

May 13, 2022

Through a collaboration, Avantor and Cytovance Biologics will accelerate plasmid optimization and sourcing services for viral vectors and mRNA-based vaccines and therapeutics.

PCI Pharma Services Invests $100 Million in Bedford, NH Manufacturing Facility

May 12, 2022

PCI Pharma Services is investing $100 million in manufacturing capabilities and capacity expansion to its Bedford, NH facility.

908 Devices and CPI Partner to Optimize Cell Culture Media for Improved Process Control

May 10, 2022

908 Devices and CPI have formed a collaboration to optimize cell culture media to allow for improved process control.